Bioimpedance rise in response to histone deacetylase inhibitor is a marker of mammary cancer cells within a mixed culture of normal breast cells

Lab on a Chip ◽  
2012 ◽  
Vol 12 (24) ◽  
pp. 5168 ◽  
Author(s):  
Vaishnavi Srinivasaraghavan ◽  
Jeannine Strobl ◽  
Masoud Agah
Keyword(s):  
Cancer Cells ◽  
Mixed Culture ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Mammary Cancer ◽  
Normal Breast ◽  
Deacetylase Inhibitor ◽  
Breast Cells ◽  
Mammary Cancer Cells

scholarly journals Histone Deacetylase Inhibitor SAHA as Potential Targeted Therapy Agent for Larynx Cancer Cells

2017 ◽  
Vol 8 (1) ◽  
pp. 19-28 ◽  
Author(s):  
Aneta Grabarska ◽  
Jarogniew J. Łuszczki ◽  
Ewa Nowosadzka ◽  
Ewelina Gumbarewicz ◽  
Witold Jeleniewicz ◽  
...  
Keyword(s):  
Targeted Therapy ◽  
Cancer Cells ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Larynx Cancer ◽  
Deacetylase Inhibitor

HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cells

2008 ◽  
Vol 19 (9) ◽  
pp. 849-857 ◽  
Author(s):  
Dennis Wegener ◽  
Hedwig E. Deubzer ◽  
Ina Oehme ◽  
Till Milde ◽  
Christian Hildmann ◽  
...  
Keyword(s):  
Childhood Cancer ◽  
Cancer Cells ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Antitumoral Activity ◽  
Deacetylase Inhibitor
Sign in / Sign up

Export Citation Format

Share Document